- Oncotech's AI-powered mobile screening app, Ophtascan™, is being launched in Romania in partnership with Medical Express, following successful trials in Central Africa. - Not only does the app offer the potential for convenient, accurate diagnoses for cancer and diabetes, but its adoption could significantly improve Romania's healthcare system.
Following demonstrated success in Central Africa, Oncotech's innovative AI-powered mobile screening app for cancer and diabetes, Ophtascan™, is set to revolutionize the healthcare systems in Romania. The program's introduction to European wellness networks follows the formation of a strategic partnership with Medical Express, signaling potential improvements in diagnoses convenience and accuracy for prevalent conditions such as cancer and diabetes.
Ophtascan™ has shown commendable performance in Central Africa, a region with a significant demand for comprehensive cancer and diabetes type 2 screening. Results from these initial trials suggested the app's significant potential in facilitating early detection and accurate diagnoses of these conditions. Sigma Africa clinicians have incorporated the use of this ground-breaking tool in their practice and have praised its user-friendly interface and reliable analysis.
Comments